Sandoz Group AG (SDZXF)
OTCMKTS · Delayed Price · Currency is USD
61.11
+0.31 (0.52%)
At close: Oct 9, 2025
Sandoz Group AG Revenue
Sandoz Group AG had revenue of $5.27 billion in the half year ending June 30, 2025, with 6.80% growth. This brings the company's revenue in the last twelve months to $10.59 billion, up 4.71% year-over-year. In the year 2024, Sandoz Group AG had annual revenue of $10.38 billion with 4.06% growth.
Revenue (ttm)
10.59B
Revenue Growth
+4.71%
P/S Ratio
2.49
Revenue / Employee
529.35K
Employees
22,049
Market Cap
26.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.38B | 405.00M | 4.06% |
| Dec 31, 2023 | 9.98B | 673.00M | 7.23% |
| Dec 31, 2022 | 9.31B | -372.00M | -3.84% |
| Dec 31, 2021 | 9.68B | 20.00M | 0.21% |
| Dec 31, 2020 | 9.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Northwest Biotherapeutics | 1.09M |
| AMJ Global Technology | 39.00 |